Announcements Trials

Browse Landscape

Phase

Status

Unknown 2 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Esophageal Squamous Cell Carcinoma 2 Uterine Cervical Neoplasms 1 Small Cell Lung Carcinoma 1 Sarcoma 1 Pleural Effusion, Malignant 1 Osteosarcoma 1 Nasopharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Carcinoma, Hepatocellular 1 Bone Neoplasms 1 Advanced Gastric Cancer 1

Interventions

Cisplatin 72 Brachytherapy 31 Radiotherapy 26 Paclitaxel 23 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21 human papillomavirus vaccine, L1 type 16, 18 20 Topotecan 18 Papillomavirus Vaccines 18 Carboplatin 18 Surveys and Questionnaires 17 Bevacizumab 16 pembrolizumab 14 Radiation 12 Gemcitabine 12 Early Intervention, Educational 12 Colposcopy 12 Methods 11 Magnetic Resonance Spectroscopy 11 atezolizumab 10 Radiotherapy, Intensity-Modulated 10 Blood Specimen Collection 10 Papanicolaou Test 9 Docetaxel 9 Vaccines, Synthetic 8 Platinum 8 Nivolumab 8 Ipilimumab 8 Counseling 8 1,2-diaminocyclohexaneplatinum II citrate 8 Vaccines 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Uterine Cervical Neoplasms × endostar protein × Clear all

NCT03086681 2025-07-29

ECWHCCFLACC

First Affiliated Hospital of Guangxi Medical University

Phase 2 Completed

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡